These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
213 related items for PubMed ID: 33331233
1. The current standing on the use of denosumab in giant cell tumour of the bone. Singh VA, Puri A. J Orthop Surg (Hong Kong); 2020; 28(3):2309499020979750. PubMed ID: 33331233 [Abstract] [Full Text] [Related]
2. Preoperative Denosumab With Curettage and Cryotherapy in Giant Cell Tumor of Bone: Is There an Increased Risk of Local Recurrence? Scoccianti G, Totti F, Scorianz M, Baldi G, Roselli G, Beltrami G, Franchi A, Capanna R, Campanacci DA. Clin Orthop Relat Res; 2018 Sep; 476(9):1783-1790. PubMed ID: 30778015 [Abstract] [Full Text] [Related]
3. Current concepts in the treatment of giant cell tumour of bone. van der Heijden L, Dijkstra S, van de Sande M, Gelderblom H. Curr Opin Oncol; 2020 Jul; 32(4):332-338. PubMed ID: 32541321 [Abstract] [Full Text] [Related]
4. Preoperative denosumab treatment with curettage may be a risk factor for recurrence of giant cell tumor of bone. Sano K, Suehara Y, Okubo T, Sasa K, Kurihara T, Akaike K, Kubota D, Torigoe T, Hasegawa N, Ishii M, Nakamura Y, Kim Y, Takagi T, Kaneko K, Hayashi T, Saito T. J Orthop Surg (Hong Kong); 2020 Jul; 28(2):2309499020929786. PubMed ID: 32539628 [Abstract] [Full Text] [Related]
5. Denosumab in patients with giant-cell tumour of bone: a multicentre, open-label, phase 2 study. Chawla S, Blay JY, Rutkowski P, Le Cesne A, Reichardt P, Gelderblom H, Grimer RJ, Choy E, Skubitz K, Seeger L, Schuetze SM, Henshaw R, Dai T, Jandial D, Palmerini E. Lancet Oncol; 2019 Dec; 20(12):1719-1729. PubMed ID: 31704134 [Abstract] [Full Text] [Related]
6. Preoperative Denosumab plus Surgery in the Management of Giant Cell Tumor of Bone: A Comprehensive Narrative Literature Review. Abu-Zaid A, Alaqaili SI, Ahmad SO, Bin Hazzaa I, Alharbi H. Gulf J Oncolog; 2019 May; 1(30):67-75. PubMed ID: 31242985 [Abstract] [Full Text] [Related]
7. Role of (Neo)adjuvant Denosumab for Giant Cell Tumor of Bone. Palmerini E, Staals EL, Jones LB, Donati DM, Longhi A, Randall RL. Curr Treat Options Oncol; 2020 Jul 04; 21(8):68. PubMed ID: 32623530 [Abstract] [Full Text] [Related]
8. Evaluation of Local Recurrence in Giant-Cell Tumor of Bone Treated by Neoadjuvant Denosumab. Chinder PS, Hindiskere S, Doddarangappa S, Pal U. Clin Orthop Surg; 2019 Sep 04; 11(3):352-360. PubMed ID: 31475058 [Abstract] [Full Text] [Related]
9. [Denosumab may be a supplement to the surgical treatment of giant cell tumours of bone]. Sørensen AL, Hansen RL, Jørgensen PH. Ugeskr Laeger; 2016 Sep 05; 178(36):. PubMed ID: 27593237 [Abstract] [Full Text] [Related]
10. Denosumab treatment of inoperable or locally advanced giant cell tumor of bone - Multicenter analysis outside clinical trial. Rutkowski P, Gaston L, Borkowska A, Stacchiotti S, Gelderblom H, Baldi GG, Palmerini E, Casali P, Gronchi A, Parry M, Campanacci DA, Scoccianti G, Wagrodzki M, Ferrari S, Dijkstra S, Pieńkowski A, Grimer R. Eur J Surg Oncol; 2018 Sep 05; 44(9):1384-1390. PubMed ID: 29650420 [Abstract] [Full Text] [Related]
11. Challenges of denosumab in giant cell tumor of bone, and other giant cell-rich tumors of bone. Lipplaa A, Dijkstra S, Gelderblom H. Curr Opin Oncol; 2019 Jul 05; 31(4):329-335. PubMed ID: 30844887 [Abstract] [Full Text] [Related]
12. Is Treatment with Denosumab Associated with Local Recurrence in Patients with Giant Cell Tumor of Bone Treated with Curettage? A Systematic Review. Tsukamoto S, Tanaka Y, Mavrogenis AF, Kido A, Kawaguchi M, Errani C. Clin Orthop Relat Res; 2020 May 05; 478(5):1076-1085. PubMed ID: 31794487 [Abstract] [Full Text] [Related]
13. Denosumab in advanced/unresectable giant-cell tumour of bone (GCTB): For how long? Palmerini E, Chawla NS, Ferrari S, Sudan M, Picci P, Marchesi E, Leopardi MP, Syed I, Sankhala KK, Parthasarathy P, Mendanha WE, Pierini M, Paioli A, Chawla SP. Eur J Cancer; 2017 May 05; 76():118-124. PubMed ID: 28324746 [Abstract] [Full Text] [Related]
14. Neoadjuvant and Adjuvant Treatment with Denosumab in Aggressive Giant-cell Tumor of Bone in the Proximal Fibula: a Case Report. Marinova VV, Slavchev SA, Patrikov KD, Tsenova PM, Georgiev GP. Folia Med (Plovdiv); 2018 Dec 01; 60(4):637-640. PubMed ID: 31188771 [Abstract] [Full Text] [Related]
15. Neoadjuvant denosumab: its role and results in operable cases of giant cell tumour of bone. Puri A, Gulia A, Hegde P, Verma V, Rekhi B. Bone Joint J; 2019 Feb 01; 101-B(2):170-177. PubMed ID: 30700112 [Abstract] [Full Text] [Related]
16. The role of Denosumab in joint preservation for patients with giant cell tumour of bone. Perrin DL, Visgauss JD, Wilson DA, Griffin AM, Abdul Razak AR, Ferguson PC, Wunder JS. Bone Joint J; 2021 Jan 01; 103-B(1):184-191. PubMed ID: 33380180 [Abstract] [Full Text] [Related]
17. Giant cell tumor of bone: current treatment options. Skubitz KM. Curr Treat Options Oncol; 2014 Sep 01; 15(3):507-18. PubMed ID: 24788576 [Abstract] [Full Text] [Related]
18. Risks and benefits of combining denosumab and surgery in giant cell tumor of bone-a case series. Müller DA, Beltrami G, Scoccianti G, Campanacci DA, Franchi A, Capanna R. World J Surg Oncol; 2016 Nov 04; 14(1):281. PubMed ID: 27809843 [Abstract] [Full Text] [Related]
19. Giant cell tumour of bone in the denosumab era. van der Heijden L, Dijkstra PDS, Blay JY, Gelderblom H. Eur J Cancer; 2017 May 04; 77():75-83. PubMed ID: 28365529 [Abstract] [Full Text] [Related]
20. A new computerized tomography classification to evaluate response to Denosumab in giant cell tumors in the extremities. Campanacci L, Sambri A, Medellin MR, Cimatti P, Errani C, Donati DM. Acta Orthop Traumatol Turc; 2019 Sep 04; 53(5):376-380. PubMed ID: 31253385 [Abstract] [Full Text] [Related] Page: [Next] [New Search]